FI972090A0 - Antibakteeriset dibentsimidatsolijohdannaiset - Google Patents

Antibakteeriset dibentsimidatsolijohdannaiset

Info

Publication number
FI972090A0
FI972090A0 FI972090A FI972090A FI972090A0 FI 972090 A0 FI972090 A0 FI 972090A0 FI 972090 A FI972090 A FI 972090A FI 972090 A FI972090 A FI 972090A FI 972090 A0 FI972090 A0 FI 972090A0
Authority
FI
Finland
Prior art keywords
antibacterial
dibenzimidazole derivatives
dibenzimidazole
derivatives
antibacterial dibenzimidazole
Prior art date
Application number
FI972090A
Other languages
English (en)
Swedish (sv)
Other versions
FI972090A (fi
Inventor
Walter Haesler
Yu-Hua Ji
Werner Leupin
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI972090A publication Critical patent/FI972090A/fi
Publication of FI972090A0 publication Critical patent/FI972090A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI972090A 1994-11-17 1997-05-15 Antibakteeriset dibentsimidatsolijohdannaiset FI972090A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH345994 1994-11-17
PCT/CH1995/000255 WO1996016042A1 (de) 1994-11-17 1995-11-02 Antibakterielle dibenzimidazol-derivate

Publications (2)

Publication Number Publication Date
FI972090A FI972090A (fi) 1997-05-15
FI972090A0 true FI972090A0 (fi) 1997-05-15

Family

ID=4256402

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972090A FI972090A0 (fi) 1994-11-17 1997-05-15 Antibakteeriset dibentsimidatsolijohdannaiset

Country Status (9)

Country Link
US (1) US5824698A (fi)
EP (1) EP0793654A1 (fi)
JP (1) JPH09512831A (fi)
AU (1) AU3696495A (fi)
BR (1) BR9509671C1 (fi)
CA (1) CA2204639A1 (fi)
FI (1) FI972090A0 (fi)
MX (1) MX9703634A (fi)
WO (1) WO1996016042A1 (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908828D0 (en) * 1999-04-16 1999-06-16 Univ Reading The Compounds
EP1191948A2 (en) * 1999-06-11 2002-04-03 Neorx Corporation High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
US6403652B1 (en) 2000-06-30 2002-06-11 Colgate-Palmolive Company Method and composition
JP2004536034A (ja) * 2001-01-08 2004-12-02 ネオルクス コーポレイション 治療的および診断的化合物、組成物および方法
US7701130B2 (en) 2001-08-24 2010-04-20 Semiconductor Energy Laboratory Co., Ltd. Luminous device with conductive film
JP2005516933A (ja) 2001-12-13 2005-06-09 ダウ グローバル テクノロジーズ インコーポレイティド 放射性医薬による骨髄炎の治療
KR100629060B1 (ko) 2004-08-11 2006-09-26 주식회사 엘지화학 새로운 벤즈이미다졸계 화합물
DE102005017508A1 (de) * 2005-04-15 2006-10-19 Basf Ag Verfahren zur Gewinnung einer basischen Aminosäure aus einer Fermentationsbrühe II
GB0821913D0 (en) 2008-12-02 2009-01-07 Price & Co Antibacterial compounds
WO2011151618A2 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile-associated disease
GB2480814A (en) * 2010-06-01 2011-12-07 Summit Corp Plc Compounds for the treatment of clostridium difficile-associated disease
AU2011260097B2 (en) 2010-06-01 2015-01-22 Summit (Oxford) Limited Compounds for the treatment of clostridium difficile associated disease
WO2011151619A1 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile associated disease
GB2480813A (en) * 2010-06-01 2011-12-07 Summit Corp Plc Compounds for the treatment of clostridium difficile-associated disease
WO2011151620A1 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile associated disease
WO2011151617A1 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile associated disease
US9079935B2 (en) 2012-08-13 2015-07-14 The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas Reducing risk of contracting Clostridium-difficile associated disease
US20180000793A1 (en) 2015-02-06 2018-01-04 Ernesto Abel-Santos Inhibiting Germination of Clostridium Perfringens Spores to Reduce Necrotic Enteritis
MX2022000598A (es) 2019-07-17 2022-03-04 Summit Oxford Ltd Preparacion de compuestos antibacterianos.
GB202100471D0 (en) 2021-01-14 2021-03-03 Summit Oxford Ltd Preparation of antibacterial compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087409A (en) * 1966-11-07 1978-05-02 Monsanto Company Ordered heterocyclic copolymers
US3484407A (en) * 1967-01-13 1969-12-16 Monsanto Co Linear condensation polymers containing carbonamide and heterocyclic linkages
US3592821A (en) * 1968-05-21 1971-07-13 Ciba Ltd 2-(2'-hydroxy-3',5'-dichlorophenyl)-5-chloro- or 5-methylbenzimidazoles
US4665066A (en) * 1984-12-24 1987-05-12 Eli Lilly And Company 3-thiazolomethyl cephalosporins as antibiotics
US4960790A (en) * 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5412059A (en) * 1993-04-05 1995-05-02 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Polybenzimidazoles via aromatic nucleophilic displacement

Also Published As

Publication number Publication date
FI972090A (fi) 1997-05-15
AU3696495A (en) 1996-06-17
BR9509671C1 (pt) 2000-04-18
CA2204639A1 (en) 1996-05-30
EP0793654A1 (de) 1997-09-10
MX9703634A (es) 1997-08-30
JPH09512831A (ja) 1997-12-22
WO1996016042A1 (de) 1996-05-30
US5824698A (en) 1998-10-20
BR9509671A (pt) 1997-10-28

Similar Documents

Publication Publication Date Title
NO952854D0 (no) 1-arylpyrimidin-derivater
DE59508427D1 (de) 3-aryl-4-hydroxy-delta 3 -dihydrothiophenon-derivate
FI972090A0 (fi) Antibakteeriset dibentsimidatsolijohdannaiset
BR9509793A (pt) Derivados de tiofeneno
DE69430587T2 (de) Pyrimidin-acyclonukleosid-derivate
NO975151D0 (no) Antibakterielle cefalosporiner
NO990463D0 (no) Azabicykliske karbamoyloksymutilinderivater for antibakteriell anvendelse
DE69524611T2 (de) Pyrimidon-derivate
EE9600011A (et) Uudsed dialkoksü-püridinüül-bensimidasooli derivaadid
DE69529799T2 (de) Aminocyclopentan-Derivate
DE69527786T2 (de) Diaminomethyliden-derivate
NO992526D0 (no) Cephalosporin-derivater
BR9506618A (pt) Derivados de difeniloxazolinas
DE69510792D1 (de) Naphtochinonderivate
BR9509877A (pt) Novos derivados de pirimidinilóxi-e piridimidinilamino- etilfenil-dioxolano
DE69515498D1 (de) Naphthyridinderivate
FI965230A (fi) Bakteerinvastaisia aineita
KR960013362A (ko) 항균제
BR9506613A (pt) Derivados de feniltio-oxazolinas
BR9508450A (pt) Derivados de n-alcóxi-amidina
NO951573D0 (no) Tiadiazinon-derivater
BR9603734A (pt) Derivados de cefalosporina
FI1384U1 (fi) Anordning foer skyddande av elektroniska apparater
FI1508U1 (fi) Av tvao olika metaller framstaelld skrovkonstruktion foer fartyg
FI1317U1 (fi) Plaotbalk foer ovanmurning av vaegghaoll